|
|
|
|
|
by haldujai
774 days ago
|
|
You’re missing that we have treatments with known risk/benefits vs research treatment X with undefined risk and reward. It’s extremely challenging if not impossible to obtain informed consent in this situation. We’ve been through this before where a fancy new treatment with promising early/lab results usurped conventional therapy only to later be found inferior. Earlier TKIs and NSCLC are a recent example that comes to mind. |
|
This is decision making under uncertainty. It's bad practice to say that uncertainty always means "don't do it".